• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Friday 07/20/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Public Offering

  • 1:22 PM

    SIMI VALLEY, Calif., May 24, 2018 /PRNewswire/ — Airborne Wireless Network (“Airborne Wireless”) (OTCQB: ABWN) today announced the pricing of an underwritten public offering (“Offering”) of 8,000 units consisting of one share of Series A Convertible Preferred Stock (“Preferred Stock”) and related warrants (“Warrants”) to purchase up to 24,000 shares of Preferred Stock, at a public offering price of $1,000 per unit, for gross proceeds of $8 million, excluding the proceeds, if any, from the exercise of the Warrants. Each share of Preferred Stock is being sold

    Read more
  • 2:52 PM

    Proceeds To Fund Commercialization of First Approved Drug and Pivotal Clinical Programs in 2018   NEW YORK, January 30, 2018 /PRNewswire/ — Q BioMed Inc. (OTCQB: QBIO) (“Q BioMed” or the “Company”), a commercial stage biotechnology acceleration development company is pleased to announce pricing of a public offering of an aggregate of 1,711,875 shares of common stock of the Company, together with warrants to purchase up to 1,711,875 shares of common stock of the Company, at a public offering price of $3.20 per share

    Read more
  • 2:57 PM

    NEW YORK, March 30, 2017, TNXP, (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (“Tonix”) (Nasdaq:TNXP), a company that is developing innovative pharmaceutical products to address public health challenges, announced today the pricing of an underwritten public offering of 1,800,000 shares of its common stock at a public offering price of $4.45 per share. The gross proceeds to Tonix from this offering are expected to be $8,010,000 before deducting underwriting discounts and commissions and other estimated offering expenses payable by Tonix. Tonix

    Read more
  • 2:17 PM

    NASDAQ: CRME TSX: COM VANCOUVER, July 29, 2016 /PRNewswire/ – Cardiome Pharma Corp. (“Cardiome” or the “Company”) (NASDAQ: CRME / TSX: COM) announced today that it has closed its previously announced underwritten public offering (the “Offering”) of 11,500,000 common shares from treasury, including the underwriters’ full exercise of their option to purchase 1,500,000 additional shares, at a price to the public of US$3.00 per common share, for aggregate gross proceeds to the Company of US$34,500,000, before deducting the underwriting commission

    Read more
  • 2:30 PM

    QUEBEC CITY, QUEBEC–(Marketwired – Jul 8, 2016) – Nemaska Lithium Inc. (“Nemaska” or the “Corporation”) (TSX:NMX) (OTCQX:NMKEF) is pleased to announce that it has completed its previously announced public offering (the “Offering”), for aggregate gross proceeds of $69,000,115. In connection with the Offering, the Corporation issued a total of 60,000,100 units of the Corporation, which included the exercise of the over-allotment option in full, at a price of $1.15 per unit (the “Offering Price”). The Offering was completed through Dundee

    Read more
  • 2:59 PM

    YAVNE, Israel, June 10, 2016, ORBK, /PRNewswire/ — ORBOTECH LTD. (the “Company” or “Orbotech“) (NASDAQ/GSM: ORBK) announced today that its previously announced public offering of 3,850,000 ordinary shares (the “Offering“) was priced at a price to the public of $26.52 per share.  The gross proceeds from the Offering before expenses are expected to be approximately$102.1 million.  The Company has also granted the underwriter an option to purchase up to 385,000 additional ordinary shares. The Company plans to use the proceeds of

    Read more
Public Wire Banner